November 13-17, 2019
Palm Springs, California

Rowan Chapman

Board Member, Evidation Health


Rowan Chapman, PhD, is a founder, investor and active independent board member of public and private companies. She previously held senior roles at J&J, GE, Mohr Davidow Ventures and several startups. In these roles she partnered with entrepreneurs to launch, invest and build companies such as Evidation Health, Adamas (IPO: ADMS), RainDance (acquired: BioRad), Pacific Biosciences (IPO: PACB), ParAllele (acquired: AFFX), Sequenta (acquired: ADPT) and Verinata (acquired: ILMN). Rowan holds a BA and PhD from the University of Cambridge in the UK.

Contact us

Like what you’ve seen? Get in touch to learn more.